Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab

S Balasubramanian, T M Nagendran*, B Ramachandran, A V Ramanan

*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

70 Citations (Scopus)
95 Downloads (Pure)

Abstract

[No abstract]
Original languageEnglish
Pages (from-to)681–683
JournalIndian Pediatrics
Volume57
Early online date10 May 2020
DOIs
Publication statusPublished - 15 Jul 2020

Research Groups and Themes

  • Covid19
  • UNCOVER

Access to Document

  • Full-text PDF (author’s accepted manuscript)

    This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Springer Verlag at https://www.indianpediatrics.net/COVID29.03.2020/CCL-00180.pdf . Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 143 KB

Handle.net

    Fingerprint

    Dive into the research topics of 'Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab'. Together they form a unique fingerprint.
    View full fingerprint

    Cite this